Westlake BioPartners


Westlake BioPartners is a life science venture capital firm that focuses on investing in entrepreneurs to create companies that develop life-saving medicines. The firm is deeply integrated into the Los Angeles biotech community, providing personal attention, hands-on support, and connections to innovative resources. Westlake BioPartners is committed to empowering entrepreneurs and guiding them from ideation to clinical and commercial impact, with a focus on addressing the greatest unmet patient needs.

Westlake BioPartners

Westlake BioPartners

3075 Townsgate Road, Suite 140, Westlake Village, CA 91361


What We Do

Westlake BioPartners invests in entrepreneurs to create companies that develop life-saving medicines. They provide personal attention, hands-on support, and connections to innovative resources.


Portfolio

Capsida Biotherapeutics is developing targeted gene therapies for genetic disorders. They have received a $40 million license payment from AbbVie and are eligible for additional milestones and royalties.

#Biotechnology

Latigo Biotherapeutics focuses on developing non-opioid pain therapeutics. They closed a $150 million Series B financing led by Blue Owl Capital.

#Biotechnology

Arsenal Biosciences is a programmable cell therapy company focused on CAR T-cell therapies for solid tumors. They closed a $220 million Series B financing round.

#Biotechnology

ACELYRIN focuses on developing transformative medicines in immunology. They closed a $300 million Series C financing to accelerate Phase 3 development of izokibep.

#Biopharmaceuticals

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.